Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMICUS THERAPEUTICS, INC. Director's Dealing 2013

Dec 3, 2013

31523_dirs_2013-12-03_15942e8a-1412-4b6d-80e4-af887b035e29.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2013-12-02

Reporting Person: Yu Julie (Vice President Clinical Ops)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock options (right to buy) $6.45 2022-02-13 Common stock (25000) Direct
Stock options (right to buy) $4.38 2022-06-04 Common stock (12500) Direct
Stock options (right to buy) $3.53 2023-01-28 Common stock (13750) Direct
Stock options (right to buy) $2.52 2023-06-18 Common stock (13750) Direct

Footnotes

F1: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on February 13, 2013. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on March 1, 2013, with the final installment vesting on February 1, 2016.

F2: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on June 4, 2013. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on July 1, 2013, with the final installment vesting on June 1, 2016.

F3: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on January 28, 2014. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on February 1, 2014, with the final installment vesting on January 1, 2017.

F4: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on June 18, 2014. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on July 1, 2014, with the final installment vesting on June 1, 2017.